Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms
Status unconfirmed · Not applicable
Conditions studied: Interstitial Cystitis, Bladder Pain Syndrome
In brief
Real-world clinical practice multicenter study to determine the clinical implications of employing PCR/NGS technology to identify and treat potential urinary pathogens in female participants identified with bladder pain and/or cystitis-like symptoms.
Key facts
- Study ID
- NCT05276466
- Run by
- MicroGenDX
- People needed
- 100
- Starts
- 2022-02-01
- Expected to finish
- 2023-12-15
- Last updated by the study team
- 2023-03-15
Who can join
Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.
Where it is running
- UCLA Center for Women's Pelvic Health — Los Angeles, California, United States (enrolling)
- The University of California San Diego Health — San Diego, California, United States (enrolling)
- Cooper University Health Care — Camden, New Jersey, United States (enrolling)
- Wake Forest University Baptist Medical Center Urology — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.